glp-1 news 2025 november trends 2025: real-world data, patient outcomes & future therapies GLP-1 Drugs: 2025 Pulse Survey

Given that obesity in adolescence is already associated with an increased risk of depression and suicidal ideation, and considering the rise in GLP-1 receptor agonist prescriptions since FDA approval in 2020, it was crucial to investigate whether this treatment impacts psychiatric outcomes

Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs

This is double the percent body weight loss seen with Ozempic and Wegovy

Physical activity plays a crucial role in promoting gut motility

Retatrutide does not have a brand name yet

GLP-1 drugs have become wildly popular as weight-loss medications, but with their increased use has come concern over the long-term safety of this class of drugs